Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
Adamax vs Semax
An educational, source-based comparison of Adamax and Semax — how each peptide works, what it's researched for, and what to know before going deeper.
A modified form of Semax with additional N-terminal adamantyl group. Research suggests enhanced stability and penetration across the blood-brain barrier, with amplified neurotrophic and neuroprotective effects compared to parent compound.
- Neuroprotection in acute ischemia
- Cognitive enhancement in healthy adults
- Recovery from traumatic brain injury
- • Russian-origin research; limited Western clinical data.
- • Not FDA-approved.
A synthetic heptapeptide derived from ACTH(4-10). Research suggests it modulates BDNF and NGF expression, dopaminergic and serotonergic tone, and shows neuroprotective effects in ischemia models.
- BDNF/NGF upregulation
- Ischemic stroke recovery (clinical use in Russia)
- Attention and cognitive performance
- Anxiolytic-style effects
- • Approved as a medication in Russia; not FDA-approved in the US.
- • Most clinical literature is in Russian.
Trial-evidence rating
Educational grade reflecting how many peer-reviewed studies and FDA actions we cite for each peptide. Not a clinical recommendation.
Early-stage research; conclusions are tentative.
Two cited studies; independent replication needed.
Study-by-study comparison
| Peptide | Study | Source | Year | Summary |
|---|---|---|---|---|
| Adamax | Adamax pharmacokinetics and neuroprotection | Molecular Neurobiology | 2019 | Enhanced BBB penetration and neuroprotective efficacy versus Semax in rodent models. |
| Semax | Semax in the treatment of ischemic stroke | Zhurnal Nevrologii i Psikhiatrii | 2018 | Reported improved neurological recovery scores in acute ischemic stroke. |
| Semax | Semax and its analogs in neuroprotection | Molecular Neurobiology | 2020 | Review of neurotrophic and antioxidant mechanisms. |
Side-effect & safety grid
- Russian-origin research; limited Western clinical data.
- Not FDA-approved.
- Approved as a medication in Russia; not FDA-approved in the US.
- Most clinical literature is in Russian.
Educational summary of considerations reported in research literature — not a complete list of adverse events. Discuss with a licensed clinician before any use.
Adamax vs Semax — Key differences
- Class: Adamax is classified as Nootropic · Neuroprotection, while Semax is Nootropic · Neuroprotection.
- Primary research focus: Adamax — neuroprotection in acute ischemia; Semax — bdnf/ngf upregulation.
- Tag: Cognition vs Cognition.